RxDoctor Payments Data

George Miguel, DO

Plastic Surgery Within the Head and Neck · Troy, MINPI 1487894754

Payments from drug & device makers

What this record shows

19 manufacturers reported payments, led by Stryker at 58.8% of the total. Reporting peaked in 2022 at $1,439 and has fallen 64.9% since, to $504 in 2025.

$4,168in general payments, 2019–2025

Across 49 payments — averaging $85.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • AbbVie$314
  • Revance Therapeutics, Inc.$288
  • Acclarent, Inc$171
  • Medtronic$155
  • Zimmer Biomet$146
  • plus $646 from 13 others

What the payments were for

  • Consulting fees$1,80043%
  • Food & beverage$2,36857%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,168 in reported general payments places this provider in the 85th percentile of 27 plastic surgery within the head and neck providers in Michigan.

See all plastic surgery within the head and neck providers in Michigan

Medicare billing

Part B allowed, 2024
$30,891
Medicare patients
45
Services billed
78

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin16$69
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$60
Ondansetron Hcl12$11

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head and neck in Troy

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →